United States
Home
P&G Network Search
Pharmaceuticals:
US Products
Consumers:
Health Care Professionals:
PROCTER & GAMBLE WINS PATENT INFRINGEMENT LAWSUIT FOR OSTEOPOROSIS THERAPY ACTONEL
CINCINNATI February 28, 2008 — Today the United States District Court of Delaware ruled in favor of The Procter & Gamble Company (P&G) in the patent infringement lawsuit filed by P&G against Teva Pharmaceuticals USA, Inc. The positive ruling protects P&G’s rights in the U.S. to exclusively market the osteoporosis therapy Actonel® (risedronate sodium tablets).
More:

Procter & Gamble Pharmaceuticals creating a world of difference
Find out more about how P&G Pharmaceuticals is improving lives every day.

Click below to view our patient testimonials.

Actonel Testimonial

Living With Osteoporosis

"I was told that I had severe osteoporosis and there is a 99% chance I would get fractures."

Dantrium Testimonial

It's a Matter of Life or Death

"We arrive into the recovery room there. Andrew is white as a ghost. He had just visited death's door....Luckily, they had it available at the hospital, and administered it quickly..... Slowly, Andrew came back to us."

Asacol Testimonial

Fighting Ulcerative Colitis

"When I was first diagnosed with ulcerative colitis, I just was at a loss to know what to do."

Touching lives, improving life. P&G


©2008 Procter & Gamble. All claims valid only in the U.S.  Legal Information  Privacy Statement  P&G Links

BBB OnLine Privacy Seal BBBOnLine Reliability Seal